Traditional Chinese medicine composition for treating asthma

Abstract

The invention relates to traditional Chinese medicine composition for treating asthma and belongs to the technical field of medicines. The traditional Chinese medicine composition comprises raw materials in parts by weight as follows: 10-15 parts of black medic herbs, 9-18 parts of rockspray, 12-18 parts of gerbera, 3-10 parts of belleric terminalia fruits, 13-19 parts of paulownia fruits, 9-15 parts of marsdenia tenacissima, 5-10 parts of henbane seeds, 10-15 parts of cymbidium ensifolium roots, 2-7 parts of tangerine pith, 6-12 parts of Argyreia acuta Lour, 10-20 parts of coix seeds, 3-9 parts of ginseng leaves, 9-12 parts of snakegourd peel, 6-12 parts of Indian damnacanthus herbs, 9-15 parts of roots of Rosthorn Bigginseng and 6-15 parts of fructus psoraleae. The traditional Chinese medicine composition has functions of clearing heat, promoting diuresis, moistening the lungs, relieving sore-throat, eliminating phlegm, stopping cough, regulating qi, dispelling wind, removing dampness, tonifying the spleen, tonifying the kidneys and the like and can be widely applied to preparation of arteriosclerosis treatment drugs, further, the curative effect is remarkable, no relapse occurs after healing, toxic and side effects are avoided, and the safety is high.

Description

【Technical field】 [0001] The invention relates to the technical field of medicine, in particular to a traditional Chinese medicine composition for treating asthma. 【technical background】 [0002] Asthma is a common and frequently-occurring disease. It is a chronic airway inflammation involving a variety of cells, especially mast cells, eosinophils, and T lymphocytes. In susceptible individuals, this inflammation can cause recurrent wheezing. Symptoms such as shortness of breath, chest tightness and (or) cough, and a small number of patients may also have chest pain as the main manifestation. Over the past ten years, the prevalence and mortality of asthma in the United States, the United Kingdom, Australia, New Zealand and other countries have been on the rise. There are about 100 million asthma patients in the world, and it has become a major chronic disease that seriously threatens public health. [0003] The pathogenesis of asthma includes: allergy, chronic airway inflamm...

AI Technical Summary

Problems solved by technology

[0004] At present, the treatment of asthma mostly adopts a combination of Chinese and Western methods, and the drugs mostly use aminophylline, ephedrine, diphenhydramine and antibiotics. Although these drugs can provide temporary relief, most of them cannot target the cause of asthma Treat the symptoms, not the root cause, and relapse easily after drug withdrawal, and some drugs have relatively large side effects, so they cannot be taken for a long time; commonly used Chinese patent medicines Qingfei Capsules, Chuanbei Tablets, etc., have small side effects, but slow curative effect and long course of treatment. The effect is not very obvious